Wealth Enhancement Advisory Services’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $470K | Buy |
53,187
+1,643
| +3% | +$14.5K | ﹤0.01% | 2256 |
|
2025
Q1 | $347K | Buy |
51,544
+10,039
| +24% | +$67.6K | ﹤0.01% | 2310 |
|
2024
Q4 | $441K | Buy |
41,505
+2,005
| +5% | +$21.3K | ﹤0.01% | 2063 |
|
2024
Q3 | $577K | Sell |
39,500
-2,070
| -5% | -$30.3K | ﹤0.01% | 1720 |
|
2024
Q2 | $503K | Buy |
41,570
+30,617
| +280% | +$370K | ﹤0.01% | 1648 |
|
2024
Q1 | $270K | Sell |
10,953
-2,047
| -16% | -$50.5K | ﹤0.01% | 1988 |
|
2023
Q4 | $139K | Buy |
+13,000
| New | +$139K | ﹤0.01% | 2134 |
|